Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

[Figure: see text]

Detalles Bibliográficos
Autores principales: Lakhotia, Rahul, Dunleavy, Kieron, Abramson, Jeremy S., Link, Brian K., Powell, Bayard L., Melani, Christopher, Lucas, Andrea N., Steinberg, Seth M., Friedberg, Jonathan W., Kahl, Brad S., Little, Richard F., Bartlett, Nancy L., Noy, Ariela, Wilson, Wyndham H., Roschewski, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506053/
https://www.ncbi.nlm.nih.gov/pubmed/37389844
http://dx.doi.org/10.1182/bloodadvances.2023010223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506053/
https://www.ncbi.nlm.nih.gov/pubmed/37389844
http://dx.doi.org/10.1182/bloodadvances.2023010223

Ejemplares similares